CURIE.BIO

curiebio-logo

Curie.Bio is a founder-focused seed-stage venture capital firm.

#Financial #More

CURIE.BIO

Status:
Active


Investments List

Date Company Article Money raised
2022-08-01 Differentiated Therapeutics Curie.Bio investment in Seed Round - Differentiated Therapeutics 5 M USD

More informations about "Curie.Bio"

Founder Guide - Curie.Bio

Curie.Bio is a new model for venture capital in biotech. We are focused on a singular mission โ€“ helping founders launch therapeutics companies that go on to raise an awesome next round of โ€ฆSee details»

How It Works โ€“ Curie.Bio

Curie.Bio has an internal, dedicated team that selects the top vendors, establishes contracts, and manages the relationships to ensure you are working with the A-team. ... Curie.Bioโ€™s teams โ€ฆSee details»

Curie.Bio - Crunchbase Investor Profile & Investments

Curie.Bio is a founder-focused seed-stage venture capital firm. Lists Featuring This Company. Edit Lists Featuring This Company Section. Venture Capital Investors with Investments in Australasia . 1,508 Number of Organizations โ€ข โ€ฆSee details»

Curie.Bio, LLC - BioCT

177 Huntington Ave Ste 1703 Boston, MA 02115-3153. Website: https://curie.bio/ Email: [email protected] General Information: Curie.Bio is a new model for venture capital in biotech โ€ฆSee details»

Curie.Bio - LinkedIn

Curie.Bio is a founder-focused seed-stage venture firm combined with an industry-grade therapeutics accelerator focused on one thing: helping entrepreneurial founders launch viable therapeutics ...See details»

Curie.Bio โ€“ Swiss Biotech

Curie.Bio is a new model for venture capital in biotech focused on helping founders launch serious therapeutics companies. We've combined two businesses in our model: we act as both your drug discovery copilot & seed โ€ฆSee details»

Biotech accelerator Curie.Bio extends its reach with โ€ฆ

Jun 26, 2024 Biotech accelerator Cure.Bio has raised $380 million for a new fund that will largely be invested in other biotechs that go through the accelerator and go on to raise a Series A round,.See details»

New VC Curie.bio makes its debut with $500m+ war โ€ฆ

Feb 15, 2023 Curie.bio says it has raised more than $500 million for its first fund, backed by the likes of ARCH Ventures, Casdin Capital, and GV, and will focus on pre-Series A start-ups that are in a ...See details»

Curie.Bio fuels up with $380M for biotech founders

Jun 26, 2024 The first company Curie.Bio took under its wingโ€”Forward Therapeuticsโ€”raised a $50 million series A in November 2023, money that was secured less than 18 months on from just $8 million of ...See details»

Curie.Bio - Investments, Portfolio & Company Exits - Crunchbase

Jul 4, 2024 Curie.Bio 's most notable exits include Celsius Therapeutics and Thrive Earlier Detection. Which industries has this organization had the most exits in? Show . Celsius โ€ฆSee details»

Our Team - Curie.Bio

Curie.Bio is run by a unique blend of world class biotech founders, operators, and early-stage investors. Our collective team has brought over 150 drugs into the clinic with 30 approvals. โ€ฆSee details»

Curie.Bio Raises $380M Pro Rata Series A Fund To Support โ€ฆ

CAMBRIDGE, Mass., June 26, 2024--Weโ€™re excited to announce today that we have closed $380 million for our latest fund, bringing the total funds raised by Curie.Bio to nearly $1 billion. These ...See details»

Curie.Bio - Funding, Financials, Valuation & Investors - Crunchbase

Apr 1, 2022 Curie.Bio has raised 2 rounds. Their latest funding was raised on Apr 1, 2022 from a Series B round. Curie.Bio is funded by 2 investors. Qiming Venture Partners and Wormhole โ€ฆSee details»

Curie.Bio Raises $380M Pro Rata Series A Fund To Support โ€ฆ

Jun 26, 2024 Curie.Bio: a better VC model for all biotech founders. We built Curie.Bio to free the founders. Curie.Bio significantly improves your ability to create impactful medicines while โ€ฆSee details»

Curie.Bio Adds $380M Series A Fund to Move Biotech Startups

Jun 26, 2024 Biotech incubator Curie.Bio has closed $380 million for its latest fund to support startup companies on the path to the clinic. The pro rata Series A fund announced on โ€ฆSee details»

Venture Report: Curie.Bioโ€™s fund; megarounds for Formation ...

Jun 28, 2024 Two-year-old investor and accelerator Curie.Bio has raised $380 million to continue building young biotechs, with a goal of preserving equity for founders as they โ€ฆSee details»

Why Curie.Bio believes it can change how new drugs get discovered

Feb 19, 2023 Serial entrepreneur Zach Weinberg explains why he started Curie.Bio to copilot promising new ideas in oncology, immunology, inflammation, and more.See details»

Two entrepreneurs try to upend the biotech funding model - STAT

Feb 14, 2023 With $520 million in hand, two entrepreneurs are trying to upend the biotech funding model with Curie.Bio.See details»

Newly founded Curie.Bio wraps up $500M+ - PitchBook

Feb 15, 2023 Newly founded Curie.Bio wraps up $500M+ February 15, 2023. Share: Curie.Bio, a VC firm focused on biotech startups, has launched with two funds totaling more than $500 โ€ฆSee details»